Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California.
Division of Internal Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.
Clin Adv Hematol Oncol. 2020 Oct;18(10):640-646.
Anemia is a common diagnosis in patients with cancer that may affect both quality of life and survival. Anemia in this patient population is often multifactorial, caused by direct effects of the malignancy, products secondary to the malignancy, the effects of treatment, or other factors. Therefore, a systematic approach is required to determine the true cause or causes of anemia. An appropriate workup of anemia in patients with cancer can lead to treatment with the potential to reduce transfusion needs and improve quality of life. The clinical benefit of these interventions for specific patients must be weighed against possible risk.
贫血是癌症患者常见的诊断，可能影响生活质量和生存。癌症患者的贫血通常是多因素的，由恶性肿瘤的直接作用、恶性肿瘤的继发产物、治疗的影响或其他因素引起。因此，需要采用系统的方法来确定贫血的真正原因。对癌症患者进行适当的贫血检查可以进行潜在的治疗，以减少输血需求并改善生活质量。这些干预措施对特定患者的临床获益必须与可能的风险相权衡。
